This inventor holds 3 USPTO granted patents and 3 published patent applications and 3 EPO patents. Top assignee: Godavari Biorefineries Limited. Active years: 2021-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2025
Title: Prashant Kharkar: Innovator in Cancer Treatment
Introduction
Prashant Kharkar is a notable inventor based in Maharashtra, India. He has made significant contributions to the field of cancer research through his innovative inventions. With a total of 3 patents, Kharkar is dedicated to developing compounds that target uncontrolled cell growth, particularly in cancer stem cells.
Latest Patents
Kharkar's latest patents include groundbreaking work on compounds for the inhibition of unregulated cell growth. The first patent discloses compounds specifically designed to inhibit uncontrolled cell proliferation, particularly targeting cancer stem cells. This invention relates to compounds of Formula I to XXII for the treatment of various cancers. His second patent focuses on anticancer compounds, which also aim to inhibit uncontrolled cell proliferation in cancer stem cells. This invention includes compounds of Formula III to XIV for the treatment of cancers such as breast and prostate cancer.
Career Highlights
Prashant Kharkar is currently associated with Godavari Biorefineries Limited, where he continues to work on innovative solutions in the field of cancer treatment. His dedication to research and development has positioned him as a key player in the industry.
Collaborations
Kharkar collaborates with talented individuals such as Sangeeta Srivastava and Sandip Gavade. Their combined expertise enhances the potential for groundbreaking discoveries in cancer research.
Conclusion
Prashant Kharkar's contributions to cancer treatment through his innovative patents highlight his commitment to advancing medical science. His work continues to inspire and pave the way for future research in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile